valsartan has been researched along with Hypokalemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cox, E; Ishigami, J; Miller, ER; Moran, AE; Pfister, M; Qin, L; Zhang, N | 1 |
| Alvarado, R; Glazer, R; Graff, A; Huang, J; Pool, JL; Weinberger, M | 1 |
1 review(s) available for valsartan and Hypokalemia
| Article | Year |
|---|---|
Dyskalemia risk associated with fixed-dose anti-hypertensive medication combinations.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Drug Combinations; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hyperkalemia; Hypertension; Hypokalemia; Tetrazoles; Valsartan | 2022 |
1 trial(s) available for valsartan and Hypokalemia
| Article | Year |
|---|---|
Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Hypokalemia; Male; Middle Aged; Tetrazoles; Valine; Valsartan | 2007 |